Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and pharmacokinetics of CKD-390(Tenofovir
Disoproxil Aspartate) and Viread® tablet(Tenofovir Disoproxil Fumarate) in healthy male
volunteers.